|First results of phase 3 trial of RTS, S/AS01 malaria vaccine in African children|
RTS, S Clinical Trials Partnership
New England Journal of Medicine 365 (20), 1863-1875, 2011
|Efficacy of RTS, S/AS01E vaccine against malaria in children 5 to 17 months of age|
P Bejon, J Lusingu, A Olotu, A Leach, M Lievens, J Vekemans, S Mshamu, ...
New England Journal of Medicine 359 (24), 2521-2532, 2008
|A phase 3 trial of RTS, S/AS01 malaria vaccine in African infants|
|Phase 1 trials of rVSV Ebola vaccine in Africa and Europe|
ST Agnandji, A Huttner, ME Zinser, P Njuguna, C Dahlke, JF Fernandes, ...
New England Journal of Medicine 374 (17), 1647-1660, 2016
|Four-year efficacy of RTS, S/AS01E and its interaction with malaria exposure|
A Olotu, G Fegan, J Wambua, G Nyangweso, KO Awuondo, A Leach, ...
New England Journal of Medicine 368 (12), 1111-1120, 2013
|Seven-year efficacy of RTS, S/AS01 malaria vaccine among young African children|
A Olotu, G Fegan, J Wambua, G Nyangweso, A Leach, M Lievens, ...
New England Journal of Medicine 374 (26), 2519-2529, 2016
|Genetic diversity and protective efficacy of the RTS, S/AS01 malaria vaccine|
DE Neafsey, M Juraska, T Bedford, D Benkeser, C Valim, A Griggs, ...
New England Journal of Medicine 373 (21), 2025-2037, 2015
|Immunogenicity of the RTS, S/AS01 malaria vaccine and implications for duration of vaccine efficacy: secondary analysis of data from a phase 3 randomised controlled trial|
MT White, R Verity, JT Griffin, KP Asante, S Owusu-Agyei, B Greenwood, ...
The Lancet infectious diseases 15 (12), 1450-1458, 2015
|Efficacy and safety of the RTS, S/AS01 malaria vaccine during 18 months after vaccination: a phase 3 randomized, controlled trial in children and young infants at 11 African sites|
RTS, S Clinical Trials Partnership (2014)
PLoS medicine 11 (7), e1001685, 2014
|Efficacy of RTS, S/AS01E malaria vaccine and exploratory analysis on anti-circumsporozoite antibody titres and protection in children aged 5–17 months in Kenya and Tanzania: a …|
A Olotu, J Lusingu, A Leach, M Lievens, J Vekemans, S Msham, T Lang, ...
The Lancet infectious diseases 11 (2), 102-109, 2011
|Risk and causes of paediatric hospital-acquired bacteraemia in Kilifi District Hospital, Kenya: a prospective cohort study|
AM Aiken, N Mturi, P Njuguna, S Mohammed, JA Berkley, I Mwangi, ...
The Lancet 378 (9808), 2021-2027, 2011
|Prime-boost vaccination with chimpanzee adenovirus and modified vaccinia Ankara encoding TRAP provides partial protection against Plasmodium falciparum infection in Kenyan adults|
C Ogwang, D Kimani, NJ Edwards, R Roberts, J Mwacharo, G Bowyer, ...
Science translational medicine 7 (286), 286re5-286re5, 2015
|Prevalence and risk factors of neurological disability and impairment in children living in rural Kenya|
V Mung'ala-Odera, R Meehan, P Njuguna, N Mturi, KJ Alcock, C Newton
International journal of epidemiology 35 (3), 683-688, 2006
|Prevalence, incidence and risk factors of epilepsy in older children in rural Kenya|
V Mung’ala-Odera, S White, R Meehan, GO Otieno, P Njuguna, N Mturi, ...
Seizure 17 (5), 396-404, 2008
|Excess child mortality after discharge from hospital in Kilifi, Kenya: a retrospective cohort analysis|
JC Moïsi, H Gatakaa, JA Berkley, K Maitland, N Mturi, CR Newton, ...
Bulletin of the World Health Organization 89, 725-732, 2011
|Effect of the Pre-erythrocytic Candidate Malaria Vaccine RTS,S/AS01E on Blood Stage Immunity in Young Children|
P Bejon, J Cook, E Bergmann-Leitner, A Olotu, J Lusingu, J Mwacharo, ...
Journal of Infectious Diseases 204 (1), 9-18, 2011
|Validity and reliability of the ‘Ten Questions’ questionnaire for detecting moderate to severe neurological impairment in children aged 6–9 years in rural Kenya|
V Mung’ala-Odera, R Meehan, P Njuguna, N Mturi, K Alcock, JA Carter, ...
Neuroepidemiology 23 (1-2), 67-72, 2004
|Evaluating controlled human malaria infection in Kenyan adults with varying degrees of prior exposure to Plasmodium falciparum using sporozoites administered by intramuscular …|
SH Hodgson, E Juma, A Salim, C Magiri, D Kimani, D Njenga, A Muia, ...
Frontiers in microbiology 5, 686, 2014
|Design of a phase III multicenter trial to evaluate the efficacy of the RTS, S/AS01 malaria vaccine in children across diverse transmission settings in Africa|
A Leach, J Vekemans, M Lievens, O Ofori-Anyinam, C Cahill, ...
Malaria journal 10 (1), 1-13, 2011
|Systems vaccinology identifies an early innate immune signature as a correlate of antibody responses to the Ebola vaccine rVSV-ZEBOV|
A Rechtien, L Richert, H Lorenzo, G Martrus, B Hejblum, C Dahlke, ...
Cell reports 20 (9), 2251-2261, 2017